АНТИМИКРОБ ЧИДАМЛИЛИК: ЗАМОНАВИЙ ТАҲДИД ВА УНИ НАЗОРАТ ҚИЛИШНИНГ ИЛМИЙ-АМАЛИЙ АСОСЛАРИ
Ключевые слова:
антимикроб чидамлилик, антибиотиклар, инфекциялар, эпидемиология, назоратАннотация
Антимикроб чидамлилик (АМЧ) замонавий тиббиётнинг энг долзарб муаммоларидан бири ҳисобланади. У инфекцион касалликларни даволаш самарадорлигини пасайтириб, асоратлар ва ўлим ҳолатларини оширишга олиб келади. Мақолада АМЧнинг этиологияси, ривожланиш омиллари ва тарқалиш механизмлари илмий манбалар асосида таҳлил қилинган. Шунингдек, антибиотикларни нотўғри ва назоратсиз қўллашнинг салбий оқибатлари ёритилган. Антимикроб чидамлиликнинг глобал ва маҳаллий даражадаги эпидемиологик хусусиятлари кўриб чиқилган. Назорат ва профилактика чоралари, жумладан антибиотиклардан оқилона фойдаланиш тамойиллари келтирилган. Соғлиқни сақлаш тизимида мониторинг ва назоратнинг аҳамияти асослаб берилган. Мақола АМЧга қарши курашда комплекс ёндашув зарурлигини таъкидлайди
##plugins.themes.default.displayStats.downloads##
Библиографические ссылки
1.World Health Organization. Global action plan on antimicrobial resistance. Geneva: WHO; 2015.
2.Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Atlanta: CDC; 2019.
3.O’Neill J. Review on antimicrobial resistance: tackling drug-resistant infections globally. London: HM Government; 2016.
4.Ventola C.L. The antibiotic resistance crisis: part 1: causes and threats. P&T. 2015;40(4):277–283.
5.Laxminarayan R., Duse A., Wattal C., et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098.
6.Davies J., Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433.
7.Holmes A.H., Moore L.S.P., Sundsfjord A., et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187.
8.Rice L.B. Mechanisms of resistance and clinical relevance. Clin Infect Dis. 2008;46(Suppl 2):S482–S489.
9.World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. Geneva: WHO; 2019.
10.Centers for Disease Control and Prevention. Core elements of hospital antibiotic stewardship programs. Atlanta: CDC; 2020.
11.European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance report. Stockholm: ECDC; 2022.
12.World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report. Geneva: WHO; 2021.
13.Allegranzi B., Pittet D. Role of hand hygiene in healthcare-associated infection prevention. Lancet. 2011;377(9761):228–241.
14.Dyar O.J., Huttner B., Schouten J., Pulcini C. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793–798.
15.World Health Organization. Laboratory quality management system handbook. Geneva: WHO; 2020.
16.Centers for Disease Control and Prevention. Guideline for infection control in healthcare facilities. Atlanta: CDC; 2019.
17.Frost L.S., Leplae R., Summers A.O., Toussaint A. Mobile genetic elements: the agents of open source evolution. Nat Rev Microbiol. 2005;3(9):722–732.
18.von Wintersdorff C.J.H., Penders J., van Niekerk J.M., et al. Dissemination of antimicrobial resistance in microbial ecosystems. Front Microbiol. 2016;7:173.
19.Partridge S.R., Kwong S.M., Firth N., Jensen S.O. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31(4):e00088-17.
20.Spellberg B., Gilbert D.N. The future of antibiotics and resistance. N Engl J Med. 2014;370(23):2296–2297.
21.World Bank. Drug-resistant infections: a threat to our economic future. Washington: World Bank; 2017.
22.World Health Organization. Antimicrobial resistance policy brief. Geneva: WHO; 2020.
23.European Centre for Disease Prevention and Control. Antimicrobial consumption report. Stockholm: ECDC; 2021.
24.World Health Organization. Diagnostic stewardship in antimicrobial resistance. Geneva: WHO; 2021.
25.Allegranzi B., Nejad S.B., Combescure C., et al. Burden of endemic health-care-associated infection. Lancet. 2011;377(9761):228–241.
26.World Health Organization. Global antimicrobial resistance surveillance system report. Geneva: WHO; 2022.
27.Centers for Disease Control and Prevention. Global antimicrobial resistance data. Atlanta: CDC; 2022.
28.Munita J.M., Arias C.A. Mechanisms of antibiotic resistance. N Engl J Med. 2016;374(7):641–651.
29.Blair J.M.A., Webber M.A., Baylay A.J., et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51.
30.Tacconelli E., Carrara E., Savoldi A., et al. Discovery, research, and development of new antibiotics. Lancet Infect Dis. 2018;18(3):318–327.
